Jubilant Pharmova Ltd. engages in the provision of basic organic chemicals. It operates through the following segments: Pharmaceuticals, Contract Research & Development Services and Proprietary Novel Drugs. The Pharmaceuticals segment engages in the maintenance and establishment of market positions in business. The Contract Research & Development Services segment engages in contract manufacturing of sterile injectable and non-sterile products and its active pharmaceutical ingredients (APIs) businesses. The Proprietary Novel Drugs segment develops breakthrough therapies in the area of oncology and auto-immune disorders. The company was founded on June 21, 1978 and is headquartered in Noida, India.